17 (9%) typical CIDP and three (7%) CIDP variant patients had elevated ANA and two (1%)/one (2%) patients had elevated ANCA antibodies, respectively. The gene discussed is BTG3; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.